---
document_datetime: 2023-09-21 20:48:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vyndaqel-epar-all-authorised-presentations_en.pdf
document_name: vyndaqel-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.884168
conversion_datetime: 2025-12-27 09:03:08.270548
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging          | Pack size                                        |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------------|--------------------------------------------------|
| EU/1/11/717/001  | Vyndaqel          | 20 mg      | Capsule, soft         | Oral use                  | blister (PVC/PA/alu/PVC-alu) | 30 x 1 capsules (unit dose)                      |
| EU/1/11/717/002  | Vyndaqel          | 20 mg      | Capsule, soft         | Oral use                  | blister (PVC/PA/alu/PVC-alu) | 90 (3 x 30 x 1) capsules (unit dose) (multipack) |
| EU/1/11/717/003  | Vyndaqel          | 61 mg      | Capsule, soft         | Oral use                  | blister (PVC/PA/alu/PVC-alu) | 30 x 1 capsules (unit dose)                      |
| EU/1/11/717/004  | Vyndaqel          | 61 mg      | Capsule, soft         | Oral use                  | blister (PVC/PA/alu/PVC-alu) | 90 (3 x 30 x 1) capsules (unit dose) (multipack) |